Filing Details
- Accession Number:
- 0001209191-19-013857
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-02-26 20:11:23
- Reporting Period:
- 2019-02-22
- Accepted Time:
- 2019-02-26 20:11:23
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 353569 | Quidel Corp | QDEL | In Vitro & In Vivo Diagnostic Substances (2835) | 942573850 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1298084 | D Thomas Brown | 29890 Tanya Trail Libertyville IL 60048 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-02-22 | 8,081 | $23.70 | 62,039 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-02-22 | 9,041 | $21.07 | 71,080 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-02-22 | 17,122 | $67.53 | 53,958 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Non-Qualified Stock Options | Disposition | 2019-02-22 | 8,081 | $0.00 | 8,081 | $23.70 |
| Common Stock | Non-Qualified Stock Options | Disposition | 2019-02-22 | 9,041 | $0.00 | 9,041 | $21.07 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2014-05-14 | 2023-05-14 | No | 4 | M | Direct |
| 0 | 2015-05-06 | 2024-05-06 | No | 4 | M | Direct |
Footnotes
- The weighted average sale price for these transactions was $67.53 per share, with a range of $67.16 to $67.98. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
Billionaire Hedge Funds
